| In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-Q | 8-K | 10-Q |
| Revenues | 28.5 | 28.5 | 28.5 | 28.5 | 0.0 |
| Cost of goods sold | 65.3 | 65.3 | 65.3 | 65.3 | 0.0 |
| Gross profit | -36.8 | -36.8 | -36.8 | -36.8 | 0.0 |
| Gross margin | -129.3% | -129.3% | -129.3% | -129.3% | |
| Selling, general and administrative [+] | 93.5 | 82.1 | 68.0 | 48.4 | 4.9 |
| General and administrative | 93.5 | 82.1 | 68.0 | 48.4 | 27.3 |
| Research and development | 59.4 | 49.2 | 39.3 | | 26.8 |
| Other operating expenses | | | | -8.3 | |
| EBITDA [+] | -178.9 | -157.6 | -133.8 | -101.8 | -59.8 |
| EBITDA growth | 199.1% | | | | |
| EBITDA margin | -628.8% | -553.8% | -470.2% | -357.9% | |
| Depreciation and amortization | 2.5 | 2.2 | 2.0 | 1.8 | 1.0 |
| EBIT [+] | -181.4 | -159.8 | -135.8 | -103.7 | -60.8 |
| EBIT growth | 198.2% | | | | |
| EBIT margin | -637.6% | -561.5% | -477.1% | -364.3% | |
| Interest expense, net [+] | -0.6 | 2.2 | 3.7 | 3.6 | 2.9 |
| Interest expense | | 2.4 | 3.8 | | 3.7 |
| Interest income | 0.9 | 0.2 | 0.1 | 0.1 | 0.9 |
| Other income (expense), net [+] | 36.2 | 33.7 | 5.3 | -16.9 | 9.3 |
| Unrealized gain/loss on derivatives | | | 16.4 | | -5.8 |
| Change in fair value of warrants | | | 16.4 | | -5.8 |
| Other | -7.2 | -7.4 | -6.7 | -6.7 | 0.0 |
| Pre-tax income | -144.6 | -128.3 | -134.2 | -124.2 | -54.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -144.6 | -128.3 | -134.2 | -124.2 | -54.4 |
| Net margin | -508.1% | -450.8% | -471.6% | -436.6% | |
| |
| Basic EPS [+] | ($0.62) | ($0.56) | ($0.89) | ($2.53) | ($0.65) |
| Growth | -4.4% | | | | |
| Diluted EPS [+] | ($0.59) | ($0.53) | ($0.82) | ($2.00) | ($0.65) |
| Growth | -9.4% | | | | |
| |
| Shares outstanding (basic) [+] | 233.2 | 229.2 | 150.4 | 49.2 | 83.9 |
| Growth | 178.1% | | | | |
| Shares outstanding (diluted) [+] | 246.2 | 242.2 | 163.4 | 62.1 | 83.9 |
| Growth | 193.5% | | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |